Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | NAAA | Q02083 | 1/20 | 0.52 |
| ▸ | RAD52 | P43351 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.48 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.46 |
| ▸ | CES2 | O00748 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | FAAH | O00519 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29117622 | 0.98 | TSHR (0.66) | TSHRALDH1A1NAAARAD52NPSR1 | |
| SCHEMBL11755056 | 0.98 | TSHR (0.66) | TSHRALDH1A1NAAARAD52NPSR1 | |
| SCHEMBL21599119 | 0.98 | TSHR (0.66) | TSHRALDH1A1NAAARAD52NPSR1 | |
| SCHEMBL859749 | 0.98 | TSHR (0.66) | TSHRALDH1A1NAAARAD52NPSR1 | |
| SCHEMBL251951 | 0.93 | ALDH1A1 (0.60) | TSHRALDH1A1NAAARAD52NPSR1 | |
| SCHEMBL29220189 | 0.91 | TSHR (0.67) | TSHRALDH1A1NAAARAD52NPSR1 | |
| Bromide SCHEMBL28460563 | 0.89 | ALDH1A1 (0.56) | TSHRALDH1A1NAAARAD52NPSR1 | |
| SCHEMBL10009304 | 0.89 | TSHR (0.70) | TSHRALDH1A1NAAARAD52NPSR1 | |
| SCHEMBL10009307 | 0.89 | TSHR (0.70) | TSHRALDH1A1NAAARAD52NPSR1 | |
| SCHEMBL29220168 | 0.89 | TSHR (0.70) | TSHRALDH1A1NAAARAD52NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | claimed |
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | disclosed |
| US-11964166-B2 | Energy augmentation structures, and their use in adhesive bonding | IMMUNOLIGHT, LLC (US) | 2024-04-23 | — | — | US | disclosed |
| EP-3160734-B1 | IMPROVED ADHESIVE BONDING COMPOSITION AND METHOD OF USE | IMMUNOLIGHT LLC (US) | 2023-09-06 | — | — | EP | disclosed |
| US-20230191747-A1 | ADHESIVE BONDING COMPOSITION AND METHOD OF USE | IMMUNOLIGHT, LLC (US) | 2023-06-22 | — | — | US | disclosed |
| US-11648750-B2 | Adhesive bonding composition and method of use | IMMUNOLIGHT, LLC (US) | 2023-05-16 | — | — | US | disclosed |
| EP-4166318-A1 | IMPROVED ADHESIVE BONDING COMPOSITION AND METHOD OF USE | Immunolight, Llc. (US) | 2023-04-19 | — | — | EP | disclosed |
| EP-3119601-B1 | IMPROVED ADHESIVE BONDING COMPOSITION AND METHOD OF USE | IMMUNOLIGHT LLC (US) | 2023-01-25 | — | — | EP | disclosed |
| US-11345833-B2 | Adhesive bonding composition and method of use | IMMUNOLIGHT, LLC (US) | 2022-05-31 | — | — | US | disclosed |
| US-20220148997-A1 | ENERGY AUGMENTATION STRUCTURES IN ADHESIVE BONDING COMPOSITIONS | IMMUNOLIGHT, LLC (US) | 2022-05-12 | — | — | US | disclosed |
| US-10410991-B2 | Adhesive bonding composition and method of use | IMMUNOLIGHT, LLC (US) | 2019-09-10 | — | — | US | disclosed |
| US-20190100680-A1 | ADHESIVE BONDING COMPOSITION AND METHOD OF USE | IMMUNOLIGHT, LLC. (US) | 2019-04-04 | — | — | US | disclosed |
| US-10087343-B2 | Adhesive bonding composition and method of use | IMMUNOLIGHT, LLC (US) | 2018-10-02 | — | — | US | disclosed |
| US-20170154866-A1 | IMPROVED ADHESIVE BONDING COMPOSITION AND METHOD OF USE | IMMUNOLIGHT, LLC (US) | 2017-06-01 | — | — | US | disclosed |
| EP-3160734-A1 | IMPROVED ADHESIVE BONDING COMPOSITION AND METHOD OF USE | Immunolight, Llc. (US) | 2017-05-03 | — | — | EP | disclosed |
| US-20170096585-A1 | IMPROVED ADHESIVE BONDING COMPOSITION AND METHOD OF USE | IMMUNOLIGHT, LLC (US) | 2017-04-06 | — | — | US | disclosed |
| EP-3119601-A1 | IMPROVED ADHESIVE BONDING COMPOSITION AND METHOD OF USE | Immunolight, Llc. (US) | 2017-01-25 | — | — | EP | disclosed |
| WO-2015143065-A1 | IMPROVED ADHESIVE BONDING COMPOSITION AND METHOD OF USE | IMMUNOLIGHT, LLC (US) | 2015-09-24 | — | — | WO | disclosed |
| WO-1996035760-A1 | BLEED RESISTANT CYANATE ESTER-CONTAINING COMPOSITIONS | QUANTUM MATERIALS, INC. (US) | 1996-11-14 | — | — | WO | disclosed |
| WO-1987003469-A1 | SOFT DENTURE LINER | GULF SOUTH RESEARCH INSTITUTE (US) | 1987-06-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11964166-B2 | Energy augmentation structures, and their use in adhesive bonding | FN1, ITGAM, ICAM1 | TSHR 3712/4885ALDH1A1 377/4885NAAA 2590/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.